FOXP3 and systemic lupus erythematosus: This controversy has been further exacerbated in the context of SLE, where CD8+CD28- T-cells have been shown to lack FOXP3, positively correlate with disease activity (SLEDAI score) and be increased in patients with lupus nephritis (49).